scholarly journals Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy

2018 ◽  
Vol Volume 11 ◽  
pp. 1491-1497 ◽  
Author(s):  
Yu-Peng Wu ◽  
Xiao-Dong Li ◽  
Zhi-Bin Ke ◽  
Shao-Hao Chen ◽  
Ping-Zhou Chen ◽  
...  
Keyword(s):  
Risk Factors ◽  
Prostate Biopsy ◽  
Transrectal Ultrasound ◽  
Infectious Complications ◽  
Ultrasound Guided

scholarly journals Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Bing-Juin Chiang ◽  
Yeong Shiau Pu ◽  
Shiu-Dong Chung ◽  
Shih-Ping Liu ◽  
Hong-Jeng Yu ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Transrectal Ultrasound ◽  
Infectious Complications ◽  
Pipemidic Acid ◽  
Ultrasound Guided ◽  
E Coli ◽  
Single Center Experience ◽  
Significant Difference ◽  
Group A ◽  
Group B

We retrospectively evaluated the efficacy of prophylaxis with pipemidic acid and levofloxacin in transrectal ultrasound guided prostate biopsy (TRUSP-Bx). From January 2002 to December 2004, patients receiving oral pipemidic acid 500 mg twice daily for three days with or without a preoperative intravenous cefazolin 1 gm injection comprised group A. Between January 2005 and December 2009, patients receiving oral levofloxacin 500 mg one hour before biopsy comprised group B. We calculated the annual febrile urinary tract infection (fUTI) rates. Patients’ characteristics, including age, prophylactic antibiotics, biopsy core numbers, pathologic results, PSA, and the spectrums and susceptibility of pathogens, were also evaluated. A total of 1313 (35.5%) patients belonged to group A, while 2381 (64.5%) patients belonged to group B. Seventy-three patients experienced postoperative infectious complications. There was a significant difference in the fUTI rate between groups A and B (3.7% versus 1.0%,P<0.001). The yearly fUTI rates varied from 0.6 to 3.9% between 2002 and 2009. Of the 73 patients with fUTI, those receiving levofloxacin prophylaxis were more likely to harbor fluoroquinolone-resistant pathogens (P<0.001).E. coliwas the most common pathogen in both groups. Levofloxacin remains effective and appears superior to pipemidic acid based prophylaxis.

scholarly journals Addition of Ceftriaxone and Amikacin to a Ciprofloxacin plus Metronidazole Regimen for Preventing Infectious Complications of Transrectal Ultrasound-Guided Prostate Biopsy: A Randomized Controlled Trial

2017 ◽  
Vol 2017 ◽  
pp. 1-5 ◽  
Author(s):  
Mohammad-Hossein Izadpanahi ◽  
Kia Nouri-Mahdavi ◽  
Seyed Mahmood Majidi ◽  
Mohammad-Hatef Khorrami ◽  
Farshid Alizadeh ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Controlled Trial ◽  
Intervention Group ◽  
Transrectal Ultrasound ◽  
Infectious Complications ◽  
Control Group ◽  
Ultrasound Guided ◽  
Prophylactic Regimen ◽  
Randomized Controlled ◽  
Group 1

Background. The objective of this study was to evaluate the efficacy of adding single doses of ceftriaxone and amikacin to a ciprofloxacin plus metronidazole regimen on the reduction of infectious complications following transrectal ultrasound-guided prostate biopsy (TRUS Bx). Materials and Methods. Four hundred and fifty patients who were candidates for TRUS Bx were divided into two groups of 225 each. The control group received ciprofloxacin 500 mg orally every 12 hours together with metronidazole 500 mg orally every 8 hours from the day prior to the procedure until the fifth postoperative day. In the second group, single doses of ceftriaxone 1 g by intravenous infusion and amikacin 5 mg/kg intramuscularly were administered 30–60 minutes before TRUS Bx in addition to the oral antimicrobials described for group 1. The incidence of infection was compared between the groups. Results. The incidence of infectious complications in the intervention group was significantly lower than that in the control group (4.6% versus 0.9%, p=0.017). Conclusion. The addition of single doses of intramuscular amikacin and intravenously infused ceftriaxone to our prophylactic regimen of ciprofloxacin plus metronidazole resulted in a statistically significant reduction of infectious complications following TRUS Bx.

Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy

Urology ◽  
2003 ◽  
Vol 62 (3) ◽  
pp. 461-466 ◽  
Author(s):  
Seong Soo Jeon ◽  
Seung-Hyo Woo ◽  
Ji-Hwan Hyun ◽  
Han Yong Choi ◽  
Soo Eung Chai
Keyword(s):  
Prostate Biopsy ◽  
Transrectal Ultrasound ◽  
Infectious Complications ◽  
Ultrasound Guided ◽  
Rectal Preparation

scholarly journals Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy

2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
Edgar Linden-Castro ◽  
Marcela Pelayo-Nieto ◽  
Alejandro Alias-Melgar ◽  
Fernando Carreño-de la Rosa
Keyword(s):  
Prostate Cancer ◽  
Single Dose ◽  
Prostate Biopsy ◽  
Antimicrobial Agents ◽  
Transrectal Ultrasound ◽  
Infectious Complications ◽  
Ultrasound Guided ◽  
Prophylactic Regimen ◽  
Local Pain ◽  
Number Of Patients

Transrectal ultrasound-guided core prostate biopsy is a key event in the diagnosis of prostate cancer, transient side events such as local pain, haematuria, haematospermia, dysuria, and rectal bleeding are reported in a large number of patients. Antimicrobial agents lower the incidence of postbiopsy infectious complications. The timing and duration of the regimen and the route of administration remain controversial. We developed a standard prophylactic regimen, in which safety and efficiency were maximized, while costs and variability were minimized. Accordingly we prospectively evaluated 425 consecutive patients, who underwent outpatient transrectal ultrasound-guided prostate biopsy after a single dose versus three doses of levofloxacin.

Sign in / Sign up

Export Citation Format

Share Document